SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 492 filers reported holding SEAGEN INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,931 | +1.8% | 103,373 | -7.6% | 0.05% | +2.1% |
| Q2 2023 | $21,542 | -5.5% | 111,929 | -0.5% | 0.05% | -9.6% |
| Q1 2023 | $22,787 | +23.9% | 112,546 | -21.4% | 0.05% | +8.3% |
| Q4 2022 | $18,397 | -99.9% | 143,156 | +44.6% | 0.05% | +20.0% |
| Q3 2022 | $13,549,000 | -46.3% | 99,020 | -30.5% | 0.04% | -40.3% |
| Q2 2022 | $25,213,000 | +31.6% | 142,494 | +7.2% | 0.07% | +67.5% |
| Q1 2022 | $19,153,000 | -10.7% | 132,961 | -4.1% | 0.04% | -20.0% |
| Q4 2021 | $21,438,000 | -19.8% | 138,671 | -11.9% | 0.05% | -25.4% |
| Q3 2021 | $26,722,000 | +1.7% | 157,374 | -5.4% | 0.07% | +8.1% |
| Q2 2021 | $26,273,000 | +27.5% | 166,406 | +12.1% | 0.06% | +10.7% |
| Q1 2021 | $20,605,000 | 0.0% | 148,382 | +26.1% | 0.06% | -6.7% |
| Q4 2020 | $20,605,000 | -51.5% | 117,651 | -45.8% | 0.06% | -11.8% |
| Q3 2020 | $42,496,000 | – | 217,156 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |